| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |